Heron Therapeutics, Inc. (HRTX) stock
HRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.28−0.00 (-0.74%)
Close on Nov 17, 2026Market cap $53.58MP/E –Yield –
Heron Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Heron Therapeutics's price to sales ratio was 0.4× on Nov 11, 2026, against 1.3× a year earlier. Over the last 5 years it ranged from 0.3× to 18.0×, with a median of 2.1×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.4× | −1.0 |
| 2025 | Dec 31, 2025 | 1.4× | −0.3 |
| 2024 | Dec 31, 2024 | 1.7× | −0.1 |
| 2023 | Dec 29, 2023 | 1.7× | −3.6 |
| 2022 | Apr 29, 2022 | 5.3× | −4.8 |
| 2021 | Dec 31, 2021 | 10.1× | −8.4 |
| 2020 | Dec 31, 2020 | 18.5× | +5.2 |
| 2019 | Dec 31, 2019 | 13.3× | −16.8 |
| 2018 | Dec 31, 2018 | 30.1× | −10.6 |
| 2017 | Dec 29, 2017 | 40.7× | – |
See a number that looks wrong?